Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$99.27 USD

99.27
4,182,726

+1.56 (1.60%)

Updated May 31, 2024 04:00 PM ET

After-Market: $99.27 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (151 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Here's Why You Should Hold on to Masimo (MASI) Stock Now

Masimo (MASI) raises 2019 revenue and EPS guidance.

Zacks.com featured highlights include: Bristol-Myers Squibb, Urban Outfitters, Hewlett Packard, Cardinal Health and British American Tobacco

Zacks.com featured highlights include: Bristol-Myers Squibb, Urban Outfitters, Hewlett Packard, Cardinal Health and British American Tobacco

Here's Why You Should Retain PRA Health (PRAH) Stock Now

PRA Health (PRAH) is gaining steadily from expansion in international markets, solid 2019 outlook and growing CRO industry. However, escalating direct costs remain a woe.

Urmimala Biswas headshot

5 Excellent GARP Stocks With Discounted PEG

PEG-based investing becomes more rewarding when other relevant parameters are considered.

Cooper Companies' CVI Unit Gets FDA Nod, To Boost Eye Health

Cooper Companies' (COO) CVI Unit has receives FDA approval for its MiSight 1 day contact lens, which complements its commitment to eye health innovation.

Here's Why You Should Hold on to Becton, Dickinson Stock Now

Becton, Dickinson (BDX) expects tariffs to impact its bottom line in first-quarter fiscal 2020.

Why Cardinal Health (CAH) Could Be a Top Value Stock Pick

Cardinal Health (CAH) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.

Here's Why You Should Hold on to PerkinElmer Stock for Now

PerkinElmer (PKI) is gaining steadily from the core Diagnostics segment, prudent acquisitions and margin expansion. However, forex volatility remains a concern.

Here's Why You Should Hold Cooper Companies (COO) Stock Now

Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions. However, forex continues to remain a concern.

Is Deep Value ETF (DVP) a Strong ETF Right Now?

Smart Beta ETF report for DVP

Cardinal Health (CAH) Q1 Earnings & Revenues Beat Estimates

Cardinal Health (CAH) Q1 results benefit revenue growth and strong segmental performance. However, contraction in gross margin remains a concern.

Cardinal Health (CAH) Q1 Earnings and Revenues Top Estimates

Cardinal (CAH) delivered earnings and revenue surprises of 16.51% and 0.99%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Medical Products' Nov 7 Earnings Roster: ABC, CAH & More

Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have contributed to the performance of the players in the medical products space this earnings season.

Why Earnings Season Could Be Great for Cardinal Health (CAH)

Cardinal Health (CAH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Hanger (HNGR) to Report Q3 Earnings: What's in the Cards?

Hanger (HNGR) Q3 performance is likely to have benefited from strong demand for Orthotic and Prosthetic services across the board.

Can Pharmacy Services Drive CVS Health's (CVS) Q3 Earnings?

CVS Health's (CVS) Caremark legacy business is expected to have delivered a solid third quarter, backed by the company's robust execution of its formulary and cost-containment tools.

What's in the Cards for Cardinal Health (CAH) in Q1 Earnings?

Cardinal Health (CAH) Q1 earnings are likely to reflect better-than-expected performance at Pharmaceutical and Medical segments.

What's in the Cards for DaVita (DVA) This Earnings Season?

DaVita (DVA) expects to have gained from calcimimetics in the third quarter.

Can All-Line Growth Boost CVS Health's (CVS) Q3 Earnings?

The newly-incorporated Health Care Benefits business already registers top-line contributions for CVS Health (CVS).

Cardinal Health (CAH) Expected to Beat Earnings Estimates: Should You Buy?

Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Genetic Testing Drive Invitae's (NVTA) Q3 Earnings?

Several bio-pharma partnerships and acquisitions are likely to have contributed to Invitae's (NVTA) top line in Q3.

Can Dental Growth Drive Henry Schein's (HSIC) Q3 Earnings?

The robust performance of the Primescan system in Europe and the United States is expected to have contributed to Henry Schein's (HSIC) top line during Q3.

Can BD Medical Drive Becton, Dickinson's (BDX) Q4 Earnings?

Headwinds in the DCB business and unfavorable foreign exchange rates might have partially impacted Becton, Dickinson's (BDX) fiscal Q4 performance.

What's in Store for Tandem Diabetes' (TNDM) Q3 Earnings?

Growth in t:slim X2 insulin pump sales is expected to get reflected in Tandem Diabetes' (TNDM) upcoming quarterly results.

PerkinElmer (PKI) to Report Q3 Earnings: What's in Store?

Top-line growth and robust performance at Diagnostics segment are likely to have aided PerkinElmer's (PKI) Q3 earnings. However, forex is likely to have been a dampener.